Almirall (Spain)

Almirall (Spain)

Almirall, S.A. is a Spanish pharmaceutical company dedicated to medical dermatology, with headquarters in Barcelona, founded in 1944. In 2023, the company generated total revenues of €898.8 million and was the leading European company in medical dermatology. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Almirall (Spain), Spain, covering academic research published from 2000 to 2024. Read More.


Open Access Percentage

41%


Total
Publications

881


Total Open
Publications

360


Total
Citations

17K


Open Access
Percentage

41%


Total
Publications

881


Total Open
Publications

360


Total
Citations

17K

Wikipedia

Website

download

Breakdown

25% 14% 3% 58%

Publisher Open

25%

Both

14%

Other Platform Open

3%

Closed

58%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

01020304050607080Total Publications
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Open

Closed

Publisher Open

46%OA Journal

OA Journal 46%

160

Hybrid 33%

115

No Guarantees 21%

75

Other Platform Open

Domain 68%

106

Institution 42%

66

Other Internet 22%

35

Public 1%

2

Preprint 1%

1

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
107
DOI
Other Internet
21
Unknown Repository
Other Internet
14
Europe PMC
Domain
10
Elsevier - Scopus
Institution
7
Universitat de Barcelona - Dipòsit Digital de la Universitat de Barcelona
Institution
6
DANS - Data Archiving and Networked Services
Institution
5
Le Centre pour la Communication Scientifique Directe - HAL - Diderot
Institution
4
Ghent University - Ghent University Academic Bibliography
Institution
4
Belarusian State Pedagogical University - Belarusian State Pedagogical University repository
Institution
4
1 / 6

Data updated 18 August 2025

Share

Share

Share